Which has preferable valuation & earnings, MDAI or EMBC?

Embecta has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $19.65M 2.58 -$7.57M -$0.53 N/A Embecta $1.08B 0.20 $95.40M $1.90 1.94

Is MDAI or EMBC more profitable?

Embecta has a net margin of 10.73% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Embecta's return on equity. Company Net Margins Return on Equity Return on Assets Spectral AI -85.58% N/A -72.97% Embecta 10.73% -23.96% 14.12%

Does the media refer more to MDAI or EMBC?

In the previous week, Embecta had 26 more articles in the media than Spectral AI. MarketBeat recorded 38 mentions for Embecta and 12 mentions for Spectral AI. Spectral AI's average media sentiment score of 1.21 beat Embecta's score of 0.02 indicating that Spectral AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Embecta 1 Very Positive mention(s) 0 Positive mention(s) 37 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is MDAI or LUCD more profitable?

Spectral AI has a net margin of -85.58% compared to Lucid Diagnostics' net margin of -876.72%. Company Net Margins Return on Equity Return on Assets Spectral AI -85.58% N/A -72.97% Lucid Diagnostics -876.72% N/A -116.26%

Does the media refer more to MDAI or LUCD?

In the previous week, Spectral AI had 10 more articles in the media than Lucid Diagnostics. MarketBeat recorded 12 mentions for Spectral AI and 2 mentions for Lucid Diagnostics. Spectral AI's average media sentiment score of 1.21 beat Lucid Diagnostics' score of 0.45 indicating that Spectral AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lucid Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer KRMD or MDAI?

In the previous week, Spectral AI had 9 more articles in the media than KORU Medical Systems. MarketBeat recorded 12 mentions for Spectral AI and 3 mentions for KORU Medical Systems. Spectral AI's average media sentiment score of 1.21 beat KORU Medical Systems' score of 0.65 indicating that Spectral AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spectral AI 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, MDAI or INFU?

InfuSystem has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $19.65M 2.58 -$7.57M -$0.53 N/A InfuSystem $142.40M 1.33 $870K $0.38 24.63

Does the media refer more to MDAI or INFU?

In the previous week, Spectral AI had 11 more articles in the media than InfuSystem. MarketBeat recorded 12 mentions for Spectral AI and 1 mentions for InfuSystem. Spectral AI's average media sentiment score of 1.21 beat InfuSystem's score of 0.00 indicating that Spectral AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InfuSystem 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, PDEX or MDAI?

Pro-Dex has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $66.59M 2.94 $8.98M $3.62 16.94 Spectral AI $19.65M 2.58 -$7.57M -$0.53 N/A

Is PDEX or MDAI more profitable?

Pro-Dex has a net margin of 16.08% compared to Spectral AI's net margin of -85.58%. Pro-Dex's return on equity of 22.78% beat Spectral AI's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 16.08% 22.78% 14.30% Spectral AI -85.58% N/A -72.97%

Spectral AI (MDAI) Competitors

$1.60 +0.05 (+2.90%)

As of 12:45 PM Eastern

Compare

MDAI vs. EMBC, LUCD, KRMD, INFU, and PDEX

Should you buy Spectral AI stock or one of its competitors? MarketBeat compares Spectral AI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Spectral AI include Embecta (EMBC), Lucid Diagnostics (LUCD), KORU Medical Systems (KRMD), InfuSystem (INFU), and Pro-Dex (PDEX).

How does Spectral AI compare to Embecta?

Spectral AI (NASDAQ:MDAI) and Embecta (NASDAQ:EMBC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Spectral AI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Embecta has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Embecta has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.58	-$7.57M	-$0.53	N/A
Embecta	$1.08B	0.20	$95.40M	$1.90	1.94

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 93.8% of Embecta shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by company insiders. Comparatively, 1.3% of Embecta shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Spectral AI currently has a consensus price target of $4.00, indicating a potential upside of 150.78%. Embecta has a consensus price target of $11.00, indicating a potential upside of 197.70%. Given Embecta's higher possible upside, analysts clearly believe Embecta is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Embecta	2 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

Embecta has a net margin of 10.73% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-85.58%	N/A	-72.97%
Embecta	10.73%	-23.96%	14.12%

In the previous week, Embecta had 26 more articles in the media than Spectral AI. MarketBeat recorded 38 mentions for Embecta and 12 mentions for Spectral AI. Spectral AI's average media sentiment score of 1.21 beat Embecta's score of 0.02 indicating that Spectral AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Embecta	1 Very Positive mention(s)	0 Positive mention(s)	37 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Embecta beats Spectral AI on 9 of the 17 factors compared between the two stocks.

How does Spectral AI compare to Lucid Diagnostics?

Spectral AI (NASDAQ:MDAI) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

Spectral AI has higher revenue and earnings than Lucid Diagnostics. Spectral AI is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.58	-$7.57M	-$0.53	N/A
Lucid Diagnostics	$4.71M	40.57	-$58.01M	-$0.47	N/A

In the previous week, Spectral AI had 10 more articles in the media than Lucid Diagnostics. MarketBeat recorded 12 mentions for Spectral AI and 2 mentions for Lucid Diagnostics. Spectral AI's average media sentiment score of 1.21 beat Lucid Diagnostics' score of 0.45 indicating that Spectral AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lucid Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Spectral AI has a net margin of -85.58% compared to Lucid Diagnostics' net margin of -876.72%.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-85.58%	N/A	-72.97%
Lucid Diagnostics	-876.72%	N/A	-116.26%

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Comparatively, 6.9% of Lucid Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Spectral AI has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Lucid Diagnostics has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

Spectral AI presently has a consensus target price of $4.00, suggesting a potential upside of 150.78%. Lucid Diagnostics has a consensus target price of $4.19, suggesting a potential upside of 345.01%. Given Lucid Diagnostics' higher probable upside, analysts clearly believe Lucid Diagnostics is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Spectral AI beats Lucid Diagnostics on 10 of the 16 factors compared between the two stocks.

How does Spectral AI compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, Spectral AI had 9 more articles in the media than KORU Medical Systems. MarketBeat recorded 12 mentions for Spectral AI and 3 mentions for KORU Medical Systems. Spectral AI's average media sentiment score of 1.21 beat KORU Medical Systems' score of 0.65 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spectral AI	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

KORU Medical Systems has a net margin of -5.27% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Spectral AI	-85.58%	N/A	-72.97%

KORU Medical Systems presently has a consensus price target of $7.25, suggesting a potential upside of 69.39%. Spectral AI has a consensus price target of $4.00, suggesting a potential upside of 150.78%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

KORU Medical Systems has higher revenue and earnings than Spectral AI. KORU Medical Systems is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$43.26M	4.54	-$2.64M	-$0.05	N/A
Spectral AI	$19.65M	2.58	-$7.57M	-$0.53	N/A

KORU Medical Systems has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

Summary

Spectral AI beats KORU Medical Systems on 9 of the 17 factors compared between the two stocks.

How does Spectral AI compare to InfuSystem?

Spectral AI (NASDAQ:MDAI) and InfuSystem (NYSE:INFU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

In the previous week, Spectral AI had 11 more articles in the media than InfuSystem. MarketBeat recorded 12 mentions for Spectral AI and 1 mentions for InfuSystem. Spectral AI's average media sentiment score of 1.21 beat InfuSystem's score of 0.00 indicating that Spectral AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InfuSystem	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InfuSystem has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.58	-$7.57M	-$0.53	N/A
InfuSystem	$142.40M	1.33	$870K	$0.38	24.63

InfuSystem has a net margin of 1.12% compared to Spectral AI's net margin of -85.58%. InfuSystem's return on equity of 2.78% beat Spectral AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-85.58%	N/A	-72.97%
InfuSystem	1.12%	2.78%	1.41%

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 13.7% of Spectral AI shares are held by company insiders. Comparatively, 10.8% of InfuSystem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Spectral AI has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market. Comparatively, InfuSystem has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

Spectral AI currently has a consensus target price of $4.00, suggesting a potential upside of 150.78%. InfuSystem has a consensus target price of $15.00, suggesting a potential upside of 60.26%. Given Spectral AI's higher probable upside, research analysts clearly believe Spectral AI is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

InfuSystem beats Spectral AI on 10 of the 16 factors compared between the two stocks.

How does Spectral AI compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Pro-Dex has a beta of 0.02, meaning that its share price is 98% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

Pro-Dex currently has a consensus target price of $70.00, indicating a potential upside of 14.15%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 150.78%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Spectral AI had 12 more articles in the media than Pro-Dex. MarketBeat recorded 12 mentions for Spectral AI and 0 mentions for Pro-Dex. Spectral AI's average media sentiment score of 1.21 beat Pro-Dex's score of 0.00 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Overall Sentiment
Pro-Dex	Neutral
Spectral AI	Positive

Pro-Dex has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59M	2.94	$8.98M	$3.62	16.94
Spectral AI	$19.65M	2.58	-$7.57M	-$0.53	N/A

Pro-Dex has a net margin of 16.08% compared to Spectral AI's net margin of -85.58%. Pro-Dex's return on equity of 22.78% beat Spectral AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
Spectral AI	-85.58%	N/A	-72.97%

Summary

Pro-Dex beats Spectral AI on 9 of the 16 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDAI vs. The Competition

Export

Metric	Spectral AI	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$50.75M	$5.69B	$6.80B	$12.66B
Dividend Yield	N/A	1.79%	2.59%	10.03%
P/E Ratio	-3.01	23.68	282.16	25.05
Price / Sales	2.58	58.86	576.18	79.91
Price / Cash	N/A	32.53	28.60	46.71
Price / Book	-8.39	6.48	10.96	6.18
Net Income	-$7.57M	$151.15M	$3.49B	$347.61M
7 Day Performance	-2.74%	2.99%	0.45%	0.71%
1 Month Performance	-10.89%	-1.58%	-4.26%	-3.75%
1 Year Performance	-32.42%	4.54%	63.09%	20.17%

Spectral AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDAI Spectral AI	2.776 of 5 stars	$1.60 +2.9%	$4.00 +150.8%	-34.3%	$50.75M	$19.65M	N/A	83	Positive News
EMBC Embecta	4.2633 of 5 stars	$3.37 -2.0%	$11.00 +226.4%	-63.5%	$204.09M	$1.08B	1.32	1,850	Upcoming Earnings
LUCD Lucid Diagnostics	3.4973 of 5 stars	$0.97 -0.3%	$4.19 +333.2%	-12.8%	$196.83M	$4.71M	N/A	70	Gap Up
KRMD KORU Medical Systems	3.4415 of 5 stars	$4.03 -0.7%	$7.25 +79.9%	+18.1%	$186.49M	$41.13M	N/A	80	Positive News Upcoming Earnings
INFU InfuSystem	4.0288 of 5 stars	$9.15 +2.3%	$15.00 +63.9%	+60.4%	$184.67M	$142.40M	152.53	410

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDAI) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Spectral AI (MDAI) Competitors

MDAI vs. EMBC, LUCD, KRMD, INFU, and PDEX

How does Spectral AI compare to Embecta?

Summary

How does Spectral AI compare to Lucid Diagnostics?

Summary

How does Spectral AI compare to KORU Medical Systems?

Summary

How does Spectral AI compare to InfuSystem?

Summary

How does Spectral AI compare to Pro-Dex?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI vs. The Competition

Spectral AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Spectral AI (MDAI) Competitors

MDAI vs. EMBC, LUCD, KRMD, INFU, and PDEX

How does Spectral AI compare to Embecta?

Which has more volatility & risk, MDAI or EMBC?

Which has preferable valuation & earnings, MDAI or EMBC?

Do institutionals and insiders believe in MDAI or EMBC?

Do analysts prefer MDAI or EMBC?

Is MDAI or EMBC more profitable?

Does the media refer more to MDAI or EMBC?

Summary

How does Spectral AI compare to Lucid Diagnostics?

Which has preferable earnings and valuation, MDAI or LUCD?

Does the media refer more to MDAI or LUCD?

Is MDAI or LUCD more profitable?

Do insiders & institutionals hold more shares of MDAI or LUCD?

Which has more volatility & risk, MDAI or LUCD?

Do analysts recommend MDAI or LUCD?

Summary

How does Spectral AI compare to KORU Medical Systems?

Does the media prefer KRMD or MDAI?

Is KRMD or MDAI more profitable?

Do analysts rate KRMD or MDAI?

Do institutionals and insiders hold more shares of KRMD or MDAI?

Which has better valuation & earnings, KRMD or MDAI?

Which has more volatility & risk, KRMD or MDAI?

Summary

How does Spectral AI compare to InfuSystem?

Does the media refer more to MDAI or INFU?

Which has better earnings & valuation, MDAI or INFU?

Is MDAI or INFU more profitable?

Do institutionals & insiders hold more shares of MDAI or INFU?

Which has more risk & volatility, MDAI or INFU?

Do analysts prefer MDAI or INFU?

Summary

How does Spectral AI compare to Pro-Dex?

Do institutionals and insiders believe in PDEX or MDAI?

Which has more risk and volatility, PDEX or MDAI?

Do analysts prefer PDEX or MDAI?

Does the media prefer PDEX or MDAI?

Which has preferable earnings & valuation, PDEX or MDAI?

Is PDEX or MDAI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI vs. The Competition

Spectral AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools